Efficacy and Acceptability of Intermittent Aerobic Exercise on Polysomnography-Measured Sleep in People With Rheumatoid Arthritis With Self-Reported Sleep Disturbance: A Randomized Controlled Trial.
Journal
ACR open rheumatology
ISSN: 2578-5745
Titre abrégé: ACR Open Rheumatol
Pays: United States
ID NLM: 101740025
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
revised:
14
08
2021
received:
27
03
2021
accepted:
16
08
2021
pubmed:
29
1
2022
medline:
29
1
2022
entrez:
28
1
2022
Statut:
ppublish
Résumé
This study's objective was to investigate the efficacy and acceptability of intermittent aerobic exercise training on sleep parameters, fatigue, pain, depressive symptoms, physical function, and cardiorespiratory fitness in people with rheumatoid arthritis (RA). Thirty-eight people with RA were assigned to intermittent aerobic exercise training (three sessions/week for 6 weeks; intervention group, n = 17) or usual care (control group, n = 21). The primary outcome was a change in polysomnography-assessed sleep efficiency from baseline to the end of the intervention. Secondary outcomes were sleep quality (Pittsburgh Sleep Quality Index), fatigue (Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire), depression (Center for Epidemiological Studies-Depression), and cardiorespiratory fitness (watt max test). No between-group differences were found in changes in polysomnography-assessed sleep efficiency (0.04; 95% confidence interval [CI]: -0.02 to 0.09, P = 0.17). In the intervention group, sleep efficiency was improved significantly from baseline (0.84; 95% CI: 0.80-0.88) compared with the end of the intervention (6 weeks) (0.88; 95% CI: 0.85-0.92); however, there was no significant difference in the control group. Fatigue and depression measures were significantly lower in the intervention group than in the control group. Between-group differences were overall fatigue (-16.1; 95% CI: -25.1 to -7.0, P = 0.001), physical fatigue (-5.0; 95% CI: -7.3 to -2.7, P = 0.0001), cognitive fatigue (-2.4; 95% CI: -4.2 to 0.6, P = 0.009), living with fatigue (-2.5; 95% CI: -4.5 to -0.5, P = 0.01), and depressive symptoms (-6.8; 95% CI: -12.4 to -1.1, P = 0.02). The intervention yielded no significantly better sleep efficiency compared with usual care. However, aspects of fatigue, including physical and cognitive fatigue, and depressive symptoms were significantly improved in the intervention group.
Identifiants
pubmed: 35089655
doi: 10.1002/acr2.11403
pmc: PMC9096512
doi:
Types de publication
Journal Article
Langues
eng
Pagination
395-405Subventions
Organisme : Novo Nordic Foundation
Organisme : Region Hovedstaden
Informations de copyright
© 2022 The Authors. ACR Open Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology.
Références
Cell. 2014 Sep 25;159(1):33-45
pubmed: 25259918
Rheumatol Int. 2015 Oct;35(10):1655-64
pubmed: 25947325
BMJ. 2009 Oct 13;339:b3410
pubmed: 19826172
Lancet. 2010 Sep 25;376(9746):1094-108
pubmed: 20870100
Rheumatol Int. 2018 May;38(5):845-853
pubmed: 29541902
JAMA. 2006 Jun 28;295(24):2851-8
pubmed: 16804151
Sleep Med. 2006 Mar;7(2):123-30
pubmed: 16459140
J Clin Sleep Med. 2015 Nov 15;11(11):1253-4
pubmed: 26446251
Ann Rheum Dis. 2017 Sep;76(9):1603-1606
pubmed: 28584189
Clin Exp Rheumatol. 2011 Nov-Dec;29(6 Suppl 69):S92-6
pubmed: 22243555
Scand J Med Sci Sports. 1995 Jun;5(3):143-6
pubmed: 7552756
Arthritis Care Res (Hoboken). 2020 Nov;72(11):1560-1570
pubmed: 31507095
Sleep Med Rev. 2008 Jun;12(3):211-28
pubmed: 18486034
Eur Respir J. 2009 Apr;33(4):907-14
pubmed: 19336593
J Rheumatol. 2014 Oct;41(10):1966-73
pubmed: 25128510
Sleep Med Rev. 2002 Apr;6(2):97-111
pubmed: 12531146
Health Qual Life Outcomes. 2013 Apr 02;11:55
pubmed: 23548052
Arthritis Care Res (Hoboken). 2018 Dec;70(12):1735-1739
pubmed: 29609204
Sleep. 2015 Jun 01;38(6):867-75
pubmed: 25515109
J Clin Sleep Med. 2011 Feb 15;7(1):49-55
pubmed: 21344040
World J Rheumatol. 2016 Jul 12;6(2):23-29
pubmed: 27489782
BMC Musculoskelet Disord. 2014 Feb 21;15:49
pubmed: 24559487
Rheumatology (Oxford). 2018 Feb 1;57(2):213-226
pubmed: 28398519
Scand J Rheumatol. 2003;32(2):108-13
pubmed: 12737330
J Sleep Res. 2017 Dec;26(6):675-700
pubmed: 28875581
Clin Rheumatol. 2015 Dec;34(12):2029-39
pubmed: 25620673
Rheumatol Int. 2021 Feb;41(2):297-310
pubmed: 33386901
Clin J Pain. 2013 Nov;29(11):988-97
pubmed: 23370082
Front Neurol. 2012 Apr 02;3:48
pubmed: 22485106
JAMA. 2009 May 20;301(19):2024-35
pubmed: 19454641
Am J Manag Care. 2006 May;12(8 Suppl):S230-45
pubmed: 16686593
Rheumatol Int. 2017 Jun;37(6):963-974
pubmed: 28251248